Wuhan Hiteck Biological Pharma Co.,Ltd (SHE:300683)

SHE:300683 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 3, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	4,283	3,121	4,727	4,322	7,273	4,225
Market Cap Growth	47.25%	-33.98%	9.35%	-40.56%	72.12%	35.86%
Enterprise Value	3,609	2,310	3,665	3,553	6,267	3,146
Last Close Price	32.72	23.70	35.90	35.19	59.21	40.64
PE Ratio	-	-	-	-	262.98	-
Forward PE	-	21.83	21.83	21.83	21.83	21.83
PS Ratio	6.91	4.81	7.85	6.28	11.83	8.06
PB Ratio	1.91	1.29	1.89	1.85	3.10	2.45
P/TBV Ratio	2.35	1.66	2.44	2.25	3.79	3.26
P/OCF Ratio	-	137.55	889.42	81.51	601.62	-
EV/Sales Ratio	5.82	3.56	6.09	5.16	10.20	6.00
EV/EBITDA Ratio	-	-	-	203.04	279.54	-
EV/FCF Ratio	-25.36	-	-	-	-	-
Debt / Equity Ratio	0.01	0.02	0.03	0.04	0.04	0.00
Debt / EBITDA Ratio	-	-	-	4.12	3.64	-
Asset Turnover	0.22	0.22	0.21	0.26	0.25	0.24
Inventory Turnover	3.68	3.37	3.11	3.74	3.75	3.41
Quick Ratio	4.11	3.23	3.88	4.46	5.85	3.35
Current Ratio	4.60	3.60	4.30	5.07	6.35	3.62
Return on Equity (ROE)	-8.19%	-3.01%	-5.31%	-0.34%	1.48%	-1.47%
Return on Assets (ROA)	-3.12%	-2.46%	-3.07%	-0.78%	-0.34%	-1.01%
Return on Invested Capital (ROIC)	-8.63%	-7.61%	-9.79%	-2.57%	-1.34%	-5.32%
Return on Capital Employed (ROCE)	-5.80%	-4.50%	-5.30%	-1.40%	-0.50%	-1.90%
Earnings Yield	-4.38%	-2.22%	-2.56%	-0.33%	0.38%	-0.59%
FCF Yield	-3.32%	-0.65%	-3.43%	-2.80%	-3.23%	-3.16%
Dividend Yield	0.43%	0.55%	-	-	-	-
Payout Ratio	-	-	-	-	0.22%	-
Buyback Yield / Dilution	3.98%	-0.71%	-1.86%	-19.91%	-2.00%	-0.91%
Total Shareholder Return	4.44%	-0.17%	-1.86%	-19.91%	-2.00%	-0.91%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.